Investment

SENS spin-out Underdog closes $10m financing round

Underdog Pharmaceuticals, a key investment of rejuvenation biotech VC Kizoo, has closed a $10 million round of capital. Michael Greve’s Kizoo...

Occuity raises over £2.5m for optical diabetes devices

UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development. DISCLOSURE:...

Fauna closes $9 million to expand drug discovery platform

Leveraging animal genomics to improve human health, Fauna Bio set to expand its comparative genomics platform for novel target drug discovery. Silicon Valley biotech startup...

Latest news

Fauna closes $9 million to expand drug discovery platform

Leveraging animal genomics to improve human health, Fauna Bio set to expand its comparative genomics platform for novel target drug discovery. Silicon Valley biotech startup...

Targeting cognitive decline with medical food

Mitocholine raising funding for clinical trial of nutritional compound that addresses cognitive decline by bridging the ‘brain energy gap’. DISCLOSURE: Longevity.Technology (a brand of First...

Investing in longevity – you are cleared for take-off

The second investors-only conference focusing on longevity is coming up later this month – we'll be there and this is why you should too. Longevity...

Shifting gear: startup aims to de-risk rejuvenation therapy

Shift Bioscience raising funding to develop safe cellular reprogramming therapies for rejuvenation. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has been contracted by the...

Impetus – getting the longevity party started

Propelling longevity research towards maximum impact, the Longevity Impetus Grants have $26m in funding to award. $26m worth of funding "towards basic research that could...

Longevity industry “taking shape”

ARDD 2021 kicks off: sessions to cover longevity topics from AI and senolytics to mitochondria and stem cell rejuvenation. Following yesterday’s workshops, ARDD 2021 really...

The need to educate in longevity

Lots to learn about longevity at ARDD 2021: from pharma and startups to physicians and high schoolers. This week, we’ll be bringing you a wealth...

Longevity-focused investors-only conference announced

The second investors-only conference focusing on longevity is set to take place on the 27th of September 2021. The Longevity Investors Conference targets the global...

Forget Love Island… welcome to Longevity Island

Consortium reveals plans to build dedicated personalised longevity resort on Maldives island. No, it’s not a concept for a new TV reality show – a...

Nurosene proposes NetraMark acquisition

Nurosene Health enters into a non-binding letter of intent with NetraMark for proposed acquisition. Nurosene Health Inc, a healthtech company focused on building a generation...

Honor acquires Home Instead – big news for aging in place

Together, Honor and Home Instead plan to transform care experience for caregivers and older adults by empowering the caregiving workforce and increasing innovation to revolutionise...

MindScopic raise $550,000 for nootropic supplements

MindScopic's nootropics are designed to improve the functioning of the brain; company will use new seed round of $550,000 to commence longevity R&D. Based in...

Gerostate passes crowdfunding goal for antiaging drug platform

Longevitytech.fund joins investment round as Buck Institute start-up continues crowdfunding campaign to move antiaging drug candidates into mammalian studies. With around two weeks still remaining...

Most popular

Crypto airdrop to support SENS Research Foundation

New crypto currency Pulse set to boost antiaging research. Cryptocurrency HEX founder Richard Heart is creating a new currency, Pulse. Prior to the launch of...

Juvenescence debuts ketosis longevity supplement drink

Biotech Juvenescence's new product Metabolic Switch is a drink that supports healthy aging and a healthy metabolism by generating a state of ketosis. It's been...

Longevity supplements report: Longevity Labs+

Longevity Labs+ – translating scientific findings into natural solutions so people can live longer, healthier lives with spermidineLIFE. Over the coming weeks, we will be...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...

You might also like

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

SENS spin-out Underdog closes $10m financing round

Underdog Pharmaceuticals, a key investment of rejuvenation biotech VC Kizoo, has closed a $10 million round of capital. Michael Greve’s Kizoo Technology Capital Group led the...
Nutriop